Optus Pharmaceutical files for approval of 'Clossi', a presbyopia drug, targeting commercialization in 2028
Predicted impact: Low
Drug approval filing with commercialization targeted for 2028; small company and distant timeline.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.